LHSIF - Liberty Health Sciences Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.5550
-0.0050 (-0.89%)
At close: 3:57PM EDT
Stock chart is not supported by your current browser
Previous Close0.5600
Open0.5582
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.5458 - 0.5730
52 Week Range0.4728 - 1.2778
Volume552,157
Avg. Volume803,345
Market Cap193.388M
Beta (3Y Monthly)5.51
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • PR Newswire2 days ago

    Liberty Health Sciences Expands Executive Leadership Team; Sheri Cholodofsky Appointed Chief Financial Officer

    TORONTO, May 22, 2019 /PRNewswire/ - Liberty Health Sciences Inc. (LHS.CN) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high quality cannabis, today announced that Sheri Cholodofsky has been appointed Chief Financial Officer, subject to Florida Department of Health approval. Cholodofsky replaces Jeff Chan, Liberty's Vice President, Finance who served as interim Chief Financial Officer following the previously announced resignation of Rene Gulliver as Chief Financial Officer effective April 14, 2019. Chan will resume his duties at Liberty as Vice President, Finance and will work closely with Cholodofsky during this transition period.

  • CNW Group18 days ago

    Liberty Health Sciences To Open Its 14th Florida Dispensary In Florida, located in Cape Coral

    TORONTO , May 6, 2019 /CNW/ - Liberty Health Sciences Inc. (LHS.CN) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high quality cannabis, announced today that it will open its 14th Florida dispensary in Cape Coral's South Cape business district on Friday, May 10 th, subject to Florida Department of Health approval. This is the first medical facility to open in Cape Coral and Liberty's second dispensary to open in Lee County . Located at 1321 SE 47th Terrace, Cape Coral, FL , the new dispensary will be open Monday through Friday, 10 a.m. to 7 p.m. , Saturday, 10 a.m. to 5 p.m. , and Sunday 12 p.m. to 5 p.m. The 3,380 square-foot facility includes innovative shopping displays that engage and educate patients, two private consultation rooms and a large waiting room where patients, physicians and community members can learn about the benefits of medical cannabis.

  • CNW Grouplast month

    Liberty Health Sciences Announces Successful Launch of Whole Flower Smokable Products; Strategic Changes

    Liberty Health Sciences Announces Successful Launch of Whole Flower Smokable Products; Strategic Changes

  • Liberty Health Sciences To Open Its 13th Florida Dispensary In Bonita Springs; Receives DOH Approval For Additional 80,000 Sq. Ft. Of Greenhouse Space
    CNW Group2 months ago

    Liberty Health Sciences To Open Its 13th Florida Dispensary In Bonita Springs; Receives DOH Approval For Additional 80,000 Sq. Ft. Of Greenhouse Space

    TORONTO , April 3, 2019 /CNW/ - Liberty Health Sciences Inc. (LHS.CN) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high quality cannabis, announced today that it will open its 13th Florida dispensary in Bonita Springs on April 5 th, as the company continues to expand rapidly throughout the state. On April 1 st the Company also received approval form the Florida Department of Health (DOH) for an additional use of 80,000 square feet of enclosed greenhouse space at the Liberty 360 Innovation campus in Gainesville .

  • CNW Group2 months ago

    Liberty Health Sciences Approved To Dispense Pre-Roll Products, Soon Available At Dispensaries Across Florida

    Liberty will be one of the first companies to offer pre-rolls of cannabis in a variety of strains and potencies, which will be available for purchase in Liberty dispensaries across the state. Patients will now be able to smoke the substance legally under a bill (SB 182) signed into law last week by Governor Ron DeSantis , which revoked the existing ban on smoking medical marijuana. The new law provides patients the ability to access medicine in the form their doctor determines best for them, whether it's smoking medical marijuana or utilizing other delivery systems.

  • CNW Group2 months ago

    Liberty Health Sciences Enters Licensing Agreement With The Werc Shop

    TORONTO , March 28, 2019 /CNW/ - Liberty Health Sciences Inc. (LHS.CN) (OTCQX: LHSIF)www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high quality cannabis, announced today that it has entered into an in-licensed agreement with The Werc Shop for its patented and patent-pending terpene technology. The Werc Shop is a world-renowned scientific consulting group recognized as the leaders in cannabis terpene analysis and terpene-based formulations, and its cutting-edge technology will enable Liberty to provide superior, standardized, and consistent medical cannabis products to the Florida market. "We are excited to be working with such a powerful technology," said Victor E. Mancebo , interim Chief Executive Officer of Liberty.

  • CNW Group2 months ago

    Liberty Health Sciences Receives Approval to Dispense Flower Products; Pending Approval for Pre-Rolls

    TORONTO , March 25, 2019 /CNW/ - Liberty Health Sciences Inc. (LHS.CN) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high quality cannabis, announced today that it has received Florida Department of Health (DOH) approval to sell whole flower smokable products to patients in Florida , making it one of the first companies in the state to provide smokable medical marijuana in all of its dispensaries. The Company is awaiting DOH approval to provide pre-rolls to patients.

  • PR Newswire2 months ago

    Liberty Health Sciences To Open Its 12th Florida Dispensary In Gainesville

    TORONTO, March 15, 2019 /PRNewswire/ - Liberty Health Sciences Inc. (LHS.CN) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high quality cannabis, announced today that the Company is continuing its expansion in Florida and is on schedule to open its 12th dispensary in Gainesville, FL on March 20, 2019, subject to the receipt of Florida Department of Health approvals. The Gainesville area is also home to two Liberty facilities that house an aggregate of 228,880 square feet of cultivation space. Located at 12 SW 2nd Street, Gainesville, FL, the new dispensary will be open Monday through Friday, 10 a.m. to 7 p.m., Saturday, 10 a.m. to 5 p.m., and Sunday 12 p.m. to 5 p.m. The 1,934 square-foot Gainesville store will provide experienced staff who continue to guide patients through the purchasing process, provide private consultations and host monthly educational events open to the community to discuss the benefits of medicinal cannabis products.

  • GlobeNewswire3 months ago

    DEADLINE FRIDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Liberty Health Sciences Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Liberty Health Sciences Inc. (“Liberty Health” or “the Company”) (OTC: LHSIF) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between June 28, 2018 and December 3, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before March 8, 2019.

  • GlobeNewswire3 months ago

    INVESTOR DEADLINE TOMORROW: Rosen Law Firm Reminds Liberty Health Sciences Inc. Investors of Important March 8th Deadline in Securities Class Action Lawsuit – LHSIF

    NEW YORK, N.Y., March 07, 2019 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Liberty Health Sciences Inc. (OTC: LHSIF) from June.

  • ACCESSWIRE3 months ago

    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Liberty Health Science Inc. of Class Action Lawsuit and Upcoming Deadline – LHSIF

    NEW YORK, NY / ACCESSWIRE / March 5, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against, Liberty Health Science Inc. (''Liberty'' or the ''Company'') (LHSIF) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and indexed under 19-cv-00161, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise, acquired Liberty common stock between June 28, 2018, and December 3, 2018, both dates inclusive (the ''Class Period''), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the ''Exchange Act'') and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

  • GlobeNewswire3 months ago

    Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Liberty Health Sciences Inc. (LHSIF)

    Law Offices of Howard G. Smith reminds investors of the March 8, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Liberty Health Sciences Inc. (“Liberty” or the “Company”) (OTC: LHSIF) securities between June 28, 2018 and December 3, 2018, inclusive (the ''Class Period''). Liberty investors have until March 8, 2019 to file a lead plaintiff motion. Investors suffering losses on their Liberty investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.

  • GlobeNewswire3 months ago

    SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Liberty Health Science Inc. of Class Action Lawsuit and Upcoming Deadline – LHSIF

    If you are a shareholder who purchased Liberty Class A common stock between June 28, 2018, and December 3, 2018, you have until March 8, 2019, to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com.   To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980.

  • GlobeNewswire3 months ago

    CLASS ACTION ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Significant Losses From Investment In Liberty Health Sciences, Inc. (Other OTC: LHSIF) To Contact Brower Piven Before The Lead Plaintiff Deadline

    The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Liberty Health Sciences, Inc. (Other OTC: LHSIF) (“Liberty” or the “Company”) securities during the period between June 28, 2018 through December 03, 2018 inclusive (the “Class Period”).  Investors who wish to become proactively involved in the litigation have until March 08, 2019 to seek appointment as lead plaintiff. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.  The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action.  The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Liberty securities during the Class Period.  Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff.  No class has yet been certified in the above action.

  • CNW Group3 months ago

    Liberty Announces 11th Dispensary Opening in Florida, Completion of Phase 1 Construction at Liberty 360 and Strategic Changes

    TORONTO , Feb. 28, 2019 /CNW/ - Liberty Health Sciences Inc. (CSE:LHS) (LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high quality cannabis, announced today that it will be opening its latest dispensary in Orange Park, Florida , on March 1, 2019 pending Florida Department of Health (the "DOH") approvals. In supporting the growth of its dispensary openings, the Company also announced that the first phase of its construction at its Liberty 360 Innovation Campus (" Liberty 360") in Gainesville, Florida has been completed, including required inspections by the DOH, which provides the Company with an additional 80,000 square feet of cultivation space. The Company also announces that it continues to work towards increasing its directors and senior executives based in the United States , to more closely align with the US geographical focus of its business, as previously announced in its press releases of February 12 and 22, 2019.